Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin International Joint Research and Development Centre of Ophthalmology and Vision Science, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, No 251, Fukang Road, Nankai District, Tianjin, 300384, People's Republic of China.
Jincheng People's Hospital, Jincheng, 048000, Shanxi, People's Republic of China.
Stem Cell Res Ther. 2021 Jan 7;12(1):21. doi: 10.1186/s13287-020-02034-6.
Retinal degenerative diseases remain the dominant causes of blindness worldwide, and cell replacement is viewed as a promising therapeutic direction. However, the resources of seed cells are hard to obtain. To further explore this therapeutic approach, human embryonic stem extracellular vesicles (hESEVs) were extracted from human embryonic stem cells (hESCs) to inspect its effect and the possible mechanism on retinal Müller cells and retinal function.
hESEVs were extracted by multi-step differential centrifugation, whose morphologies and specific biomarkers (TSG101, CD9, CD63, and CD81) were observed and measured. After hESEVs were injected into the vitreous cavity of RCS rats, the retinal tissues and retinal functions of rats were assessed. The alteration of Müller cells and retinal progenitor cells was also recorded. Microvesicles (MVs) or exosomes (EXOs) were extracted from hESCs transfected with sh-HSP90 or pcDNA3.1-HSP9, and then incubated with Müller cells to measure the uptake of EVs, MVs, or EXOs in Müller cells by immunofluorescence. The retrodifferentiation of Müller cells was determined by measuring Vimentin and CHX10. qRT-PCR and western blot were used to detect HSP90 expression in MVs and evaluate Oct4 level in Müller cells, and Co-IP to inspect the interaction of HSP90 and Oct4.
RCS rats at the postnatal 30 days had increased retinal progenitor cells which were dedifferentiated from Müller cells. hESEVs were successfully extracted from hESCs, evidenced by morphology observation and positive expressions of specific biomarkers (TSG101, CD9, CD63, and CD81). hESEVs promoted Müller cells dedifferentiated and retrodifferentiated into retinal progenitor cells evidenced by the existence of a large amount of CHX10-positive cells in the retinal inner layer of RCS rats in response to hESEV injection. The promotive role of hESEVs was exerted by MVs demonstrated by elevated fluorescence intensity of CHX10 and suppressed Vimentin fluorescence intensity in MVs rather than in EXOs. HSP90 in MVs inhibited the retrodifferentiation of Müller cells and suppressed the expression level of Oct4 in Müller cells. Co-IP revealed that HSP90 can target Oct4 in Müller cells.
hESEVs could promote the retrodifferentiation of Müller cells into retinal progenitor cells by regulating the expression of Oct4 in Müller cells by HSP90 mediation in MVs.
视网膜退行性疾病仍是全球致盲的主要原因,细胞替代被视为一种有前途的治疗方向。然而,种子细胞的资源难以获得。为了进一步探索这种治疗方法,我们从人胚胎干细胞(hESCs)中提取了人胚胎干细胞细胞外囊泡(hESEVs),以检查其对视网膜 Müller 细胞和视网膜功能的影响和可能的机制。
通过多步差速离心法提取 hESEVs,观察和测量其形态和特异性标志物(TSG101、CD9、CD63 和 CD81)。将 hESEVs 注射到 RCS 大鼠的玻璃体腔后,评估大鼠的视网膜组织和视网膜功能。还记录了 Müller 细胞和视网膜祖细胞的变化。从转染 sh-HSP90 或 pcDNA3.1-HSP9 的 hESCs 中提取微泡(MVs)或外泌体(EXOs),然后孵育 Müller 细胞,通过免疫荧光法测量 MV、EXOs 或 EVs 在 Müller 细胞中的摄取。通过测量波形蛋白和 CHX10 来确定 Müller 细胞的逆行分化。qRT-PCR 和 Western blot 用于检测 MVs 中的 HSP90 表达,并评估 Müller 细胞中的 Oct4 水平,并用 Co-IP 检测 HSP90 和 Oct4 的相互作用。
出生后 30 天的 RCS 大鼠视网膜内源性祖细胞增多,这些祖细胞是由 Müller 细胞去分化而来的。通过形态观察和特异性标志物(TSG101、CD9、CD63 和 CD81)的阳性表达,成功地从 hESCs 中提取了 hESEVs。hESEVs 促进 Müller 细胞去分化并逆行分化为视网膜祖细胞,这在 hESEV 注射后 RCS 大鼠视网膜内层存在大量 CHX10 阳性细胞得到证实。MVs 促进了 hESEVs 的作用,表现为 CHX10 的荧光强度增加,而 MV 中的波形蛋白荧光强度降低。EXOs 而非 MVs 抑制了 HSP90 在 MVs 中的作用,从而抑制了 Müller 细胞中 Oct4 的表达水平。Co-IP 显示 HSP90 可在 Müller 细胞中靶向 Oct4。
hESEVs 可通过 HSP90 介导的 MVs 调节 Müller 细胞中 Oct4 的表达,促进 Müller 细胞向视网膜祖细胞的逆行分化。